Women's Health Telehealth: Birth Control, Menopause, PCOS, and Beyond

Women's health telehealth has expanded dramatically — from birth control access (the category that drove early adoption) to menopause management, GLP-1 programs, thyroid management, and PCOS treatment. Here's the current landscape and the specific categories where telehealth delivers most effectively for women's health needs.

Birth control and reproductive health

Birth control telehealth is among the most mature categories — platforms have been prescribing oral contraceptives, patches, and rings remotely for years. The model works: documented patient history, blood pressure check (typically self-reported or with a home cuff), prescription issued, medication shipped. States with pharmacy access laws now allow pharmacists to prescribe oral contraceptives without a physician visit, further simplifying access.

Menopause and perimenopause

Menopause hormone therapy (MHT) is increasingly available through telehealth — prescribing clinicians can review symptoms, contraindications, and family history asynchronously or synchronously. For women who find in-person OB-GYN appointments difficult to access or uncomfortable for these conversations, telehealth MHT consultation represents a real access improvement.

PCOS and androgenic conditions

Spironolactone, metformin, and inositol for PCOS management — and minoxidil or finasteride for PCOS-related hair loss in appropriate patients — are available through telehealth. The key caveat: PCOS evaluation benefits from a hormone panel (LH, FSH, total testosterone, DHEA-S, free androgen index), which good telehealth platforms will require or order. Platforms that prescribe PCOS treatment without any hormonal workup are skipping essential evaluation.